Charles E. Stacey
Vorstandsvorsitzender bei Cerecin, Inc.
Profil
Charles E.
Stacey is currently the President, Chief Executive Officer & Director at Cerecin, Inc. He has been in this position since 2015.
In terms of education, Dr. Stacey has a graduate degree from Imperial College London, an undergraduate degree from University College London, an MBA from London Business School, and a doctorate from King's College London.
Aktive Positionen von Charles E. Stacey
| Unternehmen | Position | Beginn |
|---|---|---|
Cerecin, Inc.
 Cerecin, Inc. Pharmaceuticals: MajorHealth Technology Cerecin, Inc. develops therapies to treat central nervous system disorders. It offers therapeutic treatments for Parkinson's disease, Alzheimer's disease, and other age-related memory loss disorders. The firm is also developing therapies that address metabolic deficiencies and provide an alternative energy source for brain cells. The company was founded in 2001 and is headquartered in Boulder, CO. | Vorstandsvorsitzender | 02.06.2015 |
Ausbildung von Charles E. Stacey
| London Business School | Masters Business Admin |
| Imperial College London | Graduate Degree |
| King's College London | Doctorate Degree |
| University College London | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Cerecin, Inc.
Cerecin, Inc. Pharmaceuticals: MajorHealth Technology Cerecin, Inc. develops therapies to treat central nervous system disorders. It offers therapeutic treatments for Parkinson's disease, Alzheimer's disease, and other age-related memory loss disorders. The firm is also developing therapies that address metabolic deficiencies and provide an alternative energy source for brain cells. The company was founded in 2001 and is headquartered in Boulder, CO. | Health Technology |
